Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

著者: Juan W. Valle, Arndt Vogel, Crystal S. Denlinger, Aiwu Ruth He, Li‐Yuan Bai, Р. В. Орлова, Eric Van Cutsem, Jorge Adeva, Li‐Tzong Chen, Radka Obermannová, Thomas J. Ettrich, Jen‐Shi Chen, Harpreet Wasan, Allicia C. Girvan, Wei Zhang, Jiangang Liu, Chunlao Tang, Philip J. Ebert, Amit Aggarwal, Samuel McNeely, Brian A. Moser, Joana Oliveira, Roberto Carlesi, Richard A. Walgren, Do‐Youn Oh - The Lancet 2021 被引用: 66